Advances in Hematological Malignancies
Recent centuries have witnessed remarkable progress in the domain of hematological malignancies. Novel therapies such as targeted agents, immunotherapies, and gene editing are altering the survival rates for patients with blood cancers. Research studies continue to explore these innovative strategies, offering promise for more curative treatment op